CRISPR/Cas9 technology generated a glycine to aspartate substitution at amino acid 380 (p.G380D). The p.G380D mutation is orthologous to the human pathogenic variant p.G391D seen in developmental and epileptic encephalopathy. (J:330406)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count